ARNA

Arena Pharmaceuticals, Inc. News Headlines

$4.51
*  
0.24
5.05%
Get ARNA Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading ARNA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Arena's Belviq Prescriptions Hold Up During Presidents' Day Holiday Week
2/27/2015 2:58:00 PM - Seeking Alpha


Lessons From A Dozen Years Of Short Selling
2/27/2015 10:39:00 AM - Seeking Alpha


Next Week In Biotech: Pacira PDUFA, Geron And Dendreon Report
2/27/2015 9:00:00 AM - Seeking Alpha


Orexigen's Q4 Results Disappoint, But Contrave Is Gaining Market Share
2/26/2015 4:39:00 PM - Seeking Alpha


Arena Pharma. To Present At RBC Capital Conference; Webcast At 10:00 AM ET
2/24/2015 9:00:00 AM - RTT News


Arena: Belviq Television Ads Resume After 1 Week Hiatus
2/24/2015 8:11:00 AM - Seeking Alpha


Orexigen: Contrave Scripts Pass 9,000 - Closing In On Qsymia
2/23/2015 11:00:00 AM - Seeking Alpha


Arena: Belviq Sales Show Modest Gain - Time To Assess 2015 Expectations?
2/23/2015 10:33:00 AM - Seeking Alpha


Arena's Belviq Slows At A Bad Time
2/23/2015 9:57:00 AM - Seeking Alpha


Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms
2/20/2015 9:00:00 AM - Seeking Alpha


Orexigen's Contrave Sales Recover - Investors Should Look To Europe
2/18/2015 12:02:00 PM - Seeking Alpha


Arena's Belviq Scripts Spike - Maintaining This Trajectory Important
2/18/2015 9:22:00 AM - Seeking Alpha


Vivus' Qsymia Experiencing Both Prescription Growth And Market Share Erosion
2/17/2015 8:03:00 PM - Seeking Alpha


Orexigen's Contrave Resumes Solid Growth Rate
2/17/2015 8:45:00 AM - Seeking Alpha


Arena's Belviq Hits New High Prescription Mark, But Needs Similar Future Growth
2/17/2015 8:42:00 AM - Seeking Alpha


Arena Pharma. To Present At BIO CEO Conference; Webcast At 10:30 AM ET
2/10/2015 9:30:00 AM - RTT News


Vivus' Qsymia Headed In The Wrong Direction
2/7/2015 5:44:00 AM - Seeking Alpha


Orexigen: Contrave Script Sales Dip. Why?
2/6/2015 6:36:00 PM - Seeking Alpha


Arena Scripts Grow, But Pace Is Slower Than Needed
2/6/2015 6:31:00 PM - Seeking Alpha


Arena's Belviq Keeps Up Momentum During A Flat Week
2/6/2015 4:05:00 PM - Seeking Alpha


Seeking Alpha's Biotech Weekly: Questioning Gilead, MannKind To Market, And More
2/6/2015 4:00:00 PM - Seeking Alpha


The South Korean Market For Arena's Belviq May Be Larger Than Expected
2/5/2015 1:19:00 PM - Seeking Alpha


Arena's Partner May Need To Advertise More
2/4/2015 12:37:00 PM - Seeking Alpha


Arena's Belviq Approved In South Korea - Can It Change The Dynamics?
2/4/2015 11:33:00 AM - Seeking Alpha


With Flat Qsymia Sales, Vivus May Shift Focus To Stendra/Spedra
2/3/2015 2:44:00 PM - Seeking Alpha